Long Noncoding RNAs: Clarity or Confusion?
Because They Are Such Elusive Prey, lncRNAs Have Yet to Emerge as Therapeutic Targets
Markets Expand for Single-Use Bioreactors
Biobags Offer Advantages Over Fixed-Tank Systems
The Challenges of Harmonizing Biomarker Data
Why Trial Success Depends on It
Top 10 Wall Street Losers of 2016
These Companies Lost the Most in a Down Year for Biopharma Stocks
For full access to this article login to GEN Select now.
Strategic Protein Production
Revamping and Reengineering Existing Technology Can Increase Protein Yield and Efficacy
- At the recent Cambridge Healthtech “Peptalk Conference”, a range of topics related to protein expression and characterization were covered, but the event was notable for its discussion of various approaches to the optimization of biologic therapeutics. Genes for potential therapeutic proteins can be easily cloned and expressed, but ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.